most citedNew Horizons: Pioneering Pharmaceutical R&D with Generative AI from lab to the clinic -- an industry perspective

4 citations · 4 across the 1 of their papers we have counts for

collaborators

1 paper

q-bio.QM2023★ 4 cited

New Horizons: Pioneering Pharmaceutical R&D with Generative AI from lab to the clinic -- an industry perspective

Guy Doron, Sam Genway, Mark Roberts +1

The rapid advance of generative AI is reshaping the strategic vision for R&D across industries. The unique challenges of pharmaceutical R&D will see applications of generative AI d…